These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 9008258)

  • 21. Renal hemodynamics in hypertension.
    Textor SC
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):24-9. PubMed ID: 3300290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Renal effects of the chronic inhibition of nitric oxide synthesis in cirrhotic rats with ascites].
    Ortiz MC; Fortepiani LA; Martínez-Salgado C; Eleno N; Atucha NM; López-Novoa JM; García-Estañ J
    Nefrologia; 2001; 21(6):556-64. PubMed ID: 11881425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension.
    Delles C; Jacobi J; John S; Fleischmann I; Schmieder RE
    Kidney Int; 2002 Apr; 61(4):1462-8. PubMed ID: 11918753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mechanism mediating hypertension induced by chronic inhibition of nitric oxide synthesis].
    Li X; Yuasa S; Hitomi H; Hashimoto M; Fujioka H; Kiyomoto H; Uchida K; Shoji T; Takahashi N; Matsuo H
    Nihon Jinzo Gakkai Shi; 1997 Oct; 39(7):718-27. PubMed ID: 9396239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Kidney in chronic arterial hypertension: "resetting" and the role of the renal medulla in its development].
    Postnov IuV
    Kardiologiia; 1979 Dec; 19(12):30-8. PubMed ID: 390206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of arterial blood pressure and renal sodium excretion by nitric oxide synthase in the renal medulla.
    Mattson DL; Wu F
    Acta Physiol Scand; 2000 Jan; 168(1):149-54. PubMed ID: 10691793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hormonal profile and participation of nitric oxide in salt-sensitive and salt-resistant essential arterial hypertension].
    Gómez-Fernández P; Moreno VG; Cornejo M; Vargas JC; García-Barroso C; Velasco G; Almaraz M
    Nefrologia; 2000; 20(5):415-23. PubMed ID: 11100662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained hypertension in the rat induced by chronic blockade of nitric oxide production.
    Johnson RA; Freeman RH
    Am J Hypertens; 1992 Dec; 5(12 Pt 1):919-22. PubMed ID: 1285942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blockade of pressure natriuresis induced by inhibition of renal synthesis of nitric oxide in dogs.
    Salom MG; Lahera V; Miranda-Guardiola F; Romero JC
    Am J Physiol; 1992 May; 262(5 Pt 2):F718-22. PubMed ID: 1590415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Renal hemodynamic interactions of nitric oxide and angiotensin II].
    Nakanishi K; Hamada K; Hara N; Nagai Y; Nakamura K
    Nihon Jinzo Gakkai Shi; 1998 Nov; 40(8):567-72. PubMed ID: 9893455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular changes in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.
    Lassila M; Santisteban J; Finckenberg P; Salmenperä P; Riutta A; Moilanen E; Virtanen I; Vapaatalo H; Nurminen ML
    J Physiol Pharmacol; 2001 Mar; 52(1):21-38. PubMed ID: 11321510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of L-arginine infusion in normotensive subjects with and without a family history of hypertension.
    Herlitz H; Jungersten LU; Wikstrand J; Widgren BR
    Kidney Int; 1999 Nov; 56(5):1838-45. PubMed ID: 10571792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of nitric oxide in modulating renal function and arterial pressure during chronic aldosterone excess.
    Granger JP; Kassab S; Novak J; Reckelhoff JF; Tucker B; Miller MT
    Am J Physiol; 1999 Jan; 276(1):R197-202. PubMed ID: 9887195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of nebivolol on renal nitric oxide availability and tubular function in patients with essential hypertension.
    Mose FH; Jensen JM; Therwani S; Mortensen J; Hansen AB; Bech JN; Pedersen EB
    Br J Clin Pharmacol; 2015 Sep; 80(3):425-35. PubMed ID: 25778445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphodiesterase 5 inhibition ameliorates angiotensin II-dependent hypertension and renal vascular dysfunction.
    Thieme M; Sivritas SH; Mergia E; Potthoff SA; Yang G; Hering L; Grave K; Hoch H; Rump LC; Stegbauer J
    Am J Physiol Renal Physiol; 2017 Mar; 312(3):F474-F481. PubMed ID: 28052870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal mechanisms of angiotensin II-induced hypertension.
    Granger JP; Schnackenberg CG
    Semin Nephrol; 2000 Sep; 20(5):417-25. PubMed ID: 11022893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal and haemodynamic effects of nitric oxide blockade in a Wistar assay rat during high pressure cross-circulation of an isolated denervated kidney.
    Bergström G; Rudenstam J; Creutz J; Göthberg G; Karlström G
    Acta Physiol Scand; 1995 Jun; 154(2):241-52. PubMed ID: 7572220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renoprotective effects of nitric oxide in angiotensin II-induced hypertension in the rat.
    Chin SY; Wang CT; Majid DS; Navar LG
    Am J Physiol; 1998 May; 274(5):F876-82. PubMed ID: 9612324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Demonstration of the existence of nitric oxide-independent as well as nitric oxide-dependent vasodilator mechanisms in the in situ renal circulation in near term pregnant rats.
    Chu ZM; Beilin LJ
    Br J Pharmacol; 1997 Sep; 122(2):307-15. PubMed ID: 9313940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitric oxide in the regulation of renal blood flow.
    Ito S; Carretero OA; Abe K
    New Horiz; 1995 Nov; 3(4):615-23. PubMed ID: 8574592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.